Please assess the completion status of the following clinical trial:

Trial Title: The Chimerix CMX001 Registry

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: CASE_ONLY
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Have previously completed study CMX001-301 through the Week 24 visit, or participated in another qualifying clinical study with CMX001.~* Willing and able to understand and provide written informed consent to participate in this observational study~* Willing and able to participate in all required study activities for the entire duration of the observational study (i.e., agreeable to being contacted at periodic intervals over the course of approximately 10 years following the completion of study CMX001-301 or other qualifying clinical study.~Exclusion Criteria:~* None

- Gender: ALL
- Minimum Age: 6 Months
- Maximum Age: 100 Years
- Healthy Volunteers: f

Study Arms:
- CMX001 (Type: None): Subjects who have previously participated in CMX001-301 or other CMX001 study.

Based on this trial design, predict the completion outcome and termination type (if applicable).